LHC Group, Inc. (LHCG) Insider Joshua L. Proffitt Sells 10,556 Shares of Stock

LHC Group, Inc. (NASDAQ:LHCG) insider Joshua L. Proffitt sold 10,556 shares of the company’s stock in a transaction that occurred on Thursday, May 17th. The shares were sold at an average price of $75.20, for a total value of $793,811.20. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

LHCG traded up $0.25 on Friday, hitting $75.35. 12,768 shares of the company traded hands, compared to its average volume of 300,531. The company has a market cap of $1.37 billion, a PE ratio of 31.13, a P/E/G ratio of 1.18 and a beta of 0.67. LHC Group, Inc. has a 12-month low of $73.83 and a 12-month high of $74.55. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.24.

LHC Group (NASDAQ:LHCG) last issued its earnings results on Wednesday, May 2nd. The health services provider reported $0.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.60 by $0.03. The business had revenue of $291.10 million during the quarter, compared to the consensus estimate of $295.21 million. LHC Group had a return on equity of 9.29% and a net margin of 4.07%. The company’s revenue for the quarter was up 19.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.53 EPS. sell-side analysts expect that LHC Group, Inc. will post 3.5 EPS for the current fiscal year.

LHCG has been the subject of several analyst reports. Craig Hallum upped their price objective on LHC Group from $70.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, April 4th. Jefferies Group reaffirmed a “buy” rating and set a $84.00 price objective on shares of LHC Group in a research note on Wednesday, April 4th. Stephens set a $74.00 price objective on LHC Group and gave the company a “buy” rating in a research note on Friday, March 2nd. BidaskClub raised LHC Group from a “hold” rating to a “buy” rating in a research note on Tuesday, April 10th. Finally, William Blair reaffirmed a “buy” rating on shares of LHC Group in a research note on Sunday, May 6th. Two research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $76.80.

Hedge funds have recently modified their holdings of the company. SG Americas Securities LLC purchased a new position in shares of LHC Group during the 1st quarter worth approximately $105,000. Envestnet Asset Management Inc. purchased a new position in shares of LHC Group during the 1st quarter worth approximately $134,000. LS Investment Advisors LLC raised its stake in shares of LHC Group by 249.5% during the 4th quarter. LS Investment Advisors LLC now owns 2,478 shares of the health services provider’s stock worth $152,000 after buying an additional 1,769 shares in the last quarter. Cubist Systematic Strategies LLC raised its stake in shares of LHC Group by 36.9% during the 1st quarter. Cubist Systematic Strategies LLC now owns 2,636 shares of the health services provider’s stock worth $162,000 after buying an additional 711 shares in the last quarter. Finally, Jefferies Group LLC purchased a new position in shares of LHC Group during the 4th quarter worth approximately $200,000. 89.43% of the stock is owned by institutional investors and hedge funds.

About LHC Group

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Insider Buying and Selling by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply